Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-16T17:07:57.080Z Has data issue: false hasContentIssue false

Zyprexa Velotab (olanzapine): suitable for vegetarians?

Published online by Cambridge University Press:  02 January 2018

David Leung
Affiliation:
Child and Adolescent Unit, New Street Clinic, Upper New Street, Barnsley S70 1LP, e-mail: [email protected]
Sophie Davies
Affiliation:
Northern General Hospital, Sheffield
Smeeta Wong
Affiliation:
Rotherham General Hospital, Rotherham
Rights & Permissions [Opens in a new window]

Abstract

Type
The columns
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2005. The Royal College of Psychiatrists

Zyprexa Velotab (olanzapine) is one of the most commonly used antipsychotics in the UK, but how many of us are aware that the gelatin used to make the orodispersible tablets is of bovine origin?

This would obviously impact widely upon the vegetarian, Muslim, Jewish and Hindu communities, to name but a few. There are over four million vegetarians in the UK but this number is likely to be vastly expanded by the other religious faiths described above.

We think that it is important that not only do the manufacturers of this medication publicise this constituent in their summary of product characteristics but we as healthcare professionals are knowledgeable of and culturally sensitive to our patients’ beliefs and wishes.

We are all aware that the major reason for relapse of any mental illness is poor compliance with treatment (Reference Robinson, Woerner and AlvirRobinson et al, 1999). How many of those mentioned above would continue with their Zyprexa Velotab upon discovering the formulation of their medication and how would this impact upon their trust in us? Is our current practice of prescribing this formulation to this population not analogous to offering them a roast beef dinner?

References

Robinson, D., Woerner, M. G., Alvir, J. M. et al (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241247.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.